Taken together, the results of the SEM and phenotypic cancer assays authenticate the transition of the regular epithelial MCF10A-EV phenotype towards the malignantly transformed EMT-like MCF10A-KRasG12V phenotype, secondary to constitutive activation of the oncogenic KRas. This evidence concerns the gene KRAS and cancer.